Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
2 March 2012

IN THIS ISSUE
GSK recall
Eli Lilly in Ireland
Merck KGaA restructuring
US drug shortages


GSK recalls drug made at Novartis facility
GlaxoSmithKline has recalled 394,230 bottles of its antihypertensive drug DynaCirc CR because of concerns regarding cGMP compliance and procedural controls during line clearance. More...
 
Lilly invests €330-million in biopharma manufacturing
Eli Lilly is to invest €330 million at its Kinsale campus in Ireland to create a brand new biopharmaceutical commercialisation and manufacturing facility. More...
 
Merck KGaA to restructure and cut jobs
Merck KGaA has announced measures to reduce costs and increase efficiencies that are expected to result in workforce reductions across all businesses and regions. More...
 
FDA takes steps to prevent cancer drug shortages
The FDA says it will take steps in response to the declining supply of certain cancer drugs in the US. More...
 
Follow us on Twitter
We tweet regularly about the latest news, trends and rumours hitting the web about the bio/pharma industry. Follow us to make sure you don't miss out! More...
Key Topics:

Latest blog posts
Counterfeit woes in the West
A TREAT for patients
FDA steps towards quantitative safety assessment
More blog posts

Popular articles
Evaluating impurities in drugs (Part I of III)
Report from India
Pointed debate: expert views on injectables
More articles

Upcoming events
BIO-Europe Spring (19–21 March | The Netherlands)
CPhI Japan (21–23 March | Japan)
World Companion Diagnostics Summit Europe (26–29 March | Germany)
More events

Products/Service Profiles
Hospira One 2 One

Hospira One 2 One® contract development and fill-finish manufacturing of injectable products packaged in vials, PFS, cartridges, ampoules. Broad range of capabilities: Biologics; Potent drugs; Vaccines; Cytotoxics; Beta-lactams; Lyophilization.
Read more


Event Profile
PDA

Parenteral Packaging, March 13-15, Berlin | Germany
PDA organizes this conference to address the technical and regulatory issues related to parenteral packaging. Chemical, physical and microbiological aspects will be considered and current regulatory challenges will be discussed. Two Training Courses on Container Closure Development or Selection and Utilization of Glass Containers in Pharmaceutical Packaging will be given Read more

Survey
During the past decade, what has been the most significant advance in sterile manufacturing?
Advances in microbial control and testing 18%
 
Advances in isolator technology and systems 36%
     
Advances in robotics 5%
     
Adoption of quality by design principles 23%
     
Advances in process automation 18%

This week we would like to know...

What does your company place the most emphasis on when analyzing tablet powder properties?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.